COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,797 Articles (22,527 medRxiv, 8,270 bioRxiv)

Most recent first Previous |  Page 1733: Articles 17321-17330  | Next

Modeling the evolution of SARS-CoV-2 under non-pharmaceutical interventions
Gurevich, Y., Ram, Y., Hadany, L.
10.1101/2021.02.20.21252133 — Posted: 2021-02-23
REACT-1 round 9 interim report: downward trend of SARS-CoV-2 in England inFebruary 2021 but still at high prevalence
Riley, S., Walters, C. E., Wang, H., Eales, O., Haw, D., Ainslie, K. E. C., Atchinson, C., Fronterre, C., Diggle, P. J., Ashby, D., Donnelly, C. A., Cooke, G., Barclay, W., Ward, H., Darzi, A., Elliott, P.
10.1101/2021.02.18.21251973 — Posted: 2021-02-23
Smelling Household-Odorants Effectively Screens for COVID-19
snitz, k., Honigstein, D., Weisgross, R., Ravia, A., Mishor, E., Perl, O., Karagach, S., Medhanie, A., Harel, N., Shushan, S., Roth, Y., Iravani, B., Arshamian, A., Ernst, G., Okamoto, M., Mainen, Z., Poo, C., Bonacchi, N., Monteleone, E., Dinnella, C., Spinelli, S., Marino-Sanchez, F., Ferdenzi, C., Smeets, M., Touhara, K., Bensafi, M., Hummel, T., Lundstrom, J. N., Sobel, N.
10.1101/2021.02.18.21251422 — Posted: 2021-02-23
Heterogeneity in COVID-19 severity patterns among age-gender groups: an analysis of 778 692 Mexican patients through a meta-clustering technique
Zhou, L., Romero, N., Martinez Miranda, J., Conejero, J. A., Garcia-Gomez, J. M., Saez, C.
10.1101/2021.02.21.21252132 — Posted: 2021-02-23
Evolving Infection Paradox of SARS-CoV-2: Fitness Costs Virulence?
Alam, A. S. M. R. U., Islam, O. K., Hasan, M. S., Islam, M. R., Mahmud, S., AlEmran, H. M., Jahid, I. K., Crandall, K. A., Hossain, M. A.
10.1101/2021.02.21.21252137 — Posted: 2021-02-23 Discussion: Onsite
Beliefs associated with Intentions of Non-Physician Healthcare Workers to Receive the COVID-19 Vaccine in Ontario, Canada
Desveaux, L., Savage, R., Kithulegoda, N., Thai, K., Stall, N., Ivers, N.
10.1101/2021.02.19.21251936 — Posted: 2021-02-23
Nosocomial outbreak of SARS-CoV-2 in a 'non-COVID-19' hospital ward: virus genome sequencing as a key tool to understand cryptic transmission
Borges, V., Isidro, J., Macedo, F., Neves, J., Silva, L., Paiva, M., Barata, J., Catarino, J., Ciobanu, L., Duarte, S., Vieira, L., Guiomar, R., Gomes, J. P.
10.1101/2021.02.20.20248421 — Posted: 2021-02-23 Discussion: Offsite
The spatio-temporal distribution of COVID-19 infection in England between January and June 2020.
Elson, R., Davies, T. M., Lake, I. R., Vivancos, R., Blomquist, P. B., Charlett, A., Dabrera, G.
10.1101/2021.02.22.21251534 — Posted: 2021-02-23
Group IIA Secreted Phospholipase A2 Plays a Central Role in the Pathobiology of COVID-19
Snider, J. M., You, J. K., Wang, X., Snider, A. J., Hallmark, B., Seeds, M. C., Sergeant, S., Johnstone, L., Wang, Q., Sprissler, R., Zhang, H. H., Luberto, C., Kew, R. R., Hannun, Y. A., McCall, C. E., Yao, G., Del Poeta, M., Chilton, F. H.
10.1101/2021.02.22.21252237 — Posted: 2021-02-23
COVID-19 Spreading dynamics in an age-structured population with selective relaxation of restrictions for vaccinated individuals : a mathematical modeling study
Shayak, B., Sharma, M. M., Mishra, A. K.
10.1101/2021.02.22.21252241 — Posted: 2021-02-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).